Document Detail


Discovery of a new chemical lead for a matrix metalloproteinase inhibitor.
MedLine Citation:
PMID:  16481176     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A series of N-benzoyl gamma-aminobutyric hydroxamic acids were synthesized and evaluated as matrix metalloproteinase inhibitors. First, we focused on chemical modification of the N-benzoyl residue. Introduction of electron-rich para-substituents was effective to increase the inhibitory activity. Especially, some of the analogs with relatively more planar N-acyl residues, such as 10 and 11, demonstrated more potent activity. Second, chemical modification of the gamma-aminobutyric hydroxamic acid moiety was carried out to optimize the three-dimensional arrangement of the two pharmacophores (hydroxamic acid and N-acyl residues). Among the tested, the gamma-aminobutyric hydroxamic acid moiety was found to be the best spacer for connecting the above-mentioned two pharmacophores. Synthesis and structure-activity relationships are discussed.
Authors:
Masahiro Ikura; Shingo Nakatani; Shingo Yamamoto; Hiromu Habashita; Tsuneyuki Sugiura; Kanji Takahashi; Koji Ogawa; Hiroyuki Ohno; Hisao Nakai; Masaaki Toda
Related Documents :
3362946 - 3-mercaptopropionic acid administration into the caudate-putamen of the rat provokes dy...
18652476 - Determination of theanine, gaba, and other amino acids in green, oolong, black, and pu-...
16183056 - Antidystonic efficacy of gamma-aminobutyric acid uptake inhibitors in the dtsz mutant.
1268876 - Synthesis and chemical behaviour of d-glucosyl esters of glutamic acid having the side-...
838676 - Role of teichuronic acid in bacillus licheniformis: defective autolysis due to deficien...
18961566 - Atomic-absorption determination of lead in geological materials.
Publication Detail:
Type:  Journal Article     Date:  2006-02-14
Journal Detail:
Title:  Bioorganic & medicinal chemistry     Volume:  14     ISSN:  0968-0896     ISO Abbreviation:  Bioorg. Med. Chem.     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-05-08     Completed Date:  2006-08-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9413298     Medline TA:  Bioorg Med Chem     Country:  England    
Other Details:
Languages:  eng     Pagination:  4241-52     Citation Subset:  IM    
Affiliation:
Minase Research Institute, Ono Pharmaceutical Co., Ltd, 3-1-1 Sakurai, Shimamoto, Mishima, Osaka 618-8585, Japan. ikura@ono.co.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Design
Enzyme Inhibitors / chemical synthesis,  chemistry*,  pharmacology*
Humans
Matrix Metalloproteinases / antagonists & inhibitors*
Molecular Structure
Structure-Activity Relationship
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; EC 3.4.24.-/Matrix Metalloproteinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Photodynamic inactivation of Escherichia coli immobilized on agar surfaces by a tricationic porphyri...
Next Document:  EELS characterisation of bulk CaCu3Ti4O12 ceramics.